Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma

被引:39
|
作者
Allmeroth, Kira [1 ]
Horn, Moritz [2 ]
Kroef, Virginia [1 ]
Miethe, Stephan [1 ]
Mueller, Roman-Ulrich [3 ,4 ,5 ,6 ]
Denzel, Martin S. [1 ,3 ,6 ]
机构
[1] Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany
[2] Acus Labs GmbH, Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany
[3] Univ Cologne, CECAD Cluster Excellence, Joseph Stelzmann Str 26, D-50931 Cologne, Germany
[4] Univ Cologne, Fac Med, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany
[5] Univ Cologne, Univ Hosp Cologne, Kerpener Str 62, D-50937 Cologne, Germany
[6] Univ Cologne, Ctr Mol Med Cologne CMMC, Robert Koch Str 21, D-50931 Cologne, Germany
关键词
20S PROTEASOME;
D O I
10.1038/s41375-020-0989-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:887 / 892
页数:6
相关论文
共 48 条
  • [1] Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
    Kira Allmeroth
    Moritz Horn
    Virginia Kroef
    Stephan Miethe
    Roman-Ulrich Müller
    Martin S. Denzel
    Leukemia, 2021, 35 : 887 - 892
  • [2] No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to bortezomib
    Politou, M
    Karadimitris, A
    Terpos, E
    Kotsianidis, I
    Apperley, JF
    Rahemtulla, A
    LEUKEMIA RESEARCH, 2006, 30 (02) : 240 - 241
  • [3] Parallel Evolution of Multiple PSMB5 mutations in a Myeloma Patient Treated with Bortezomib
    Barrio, Santiago
    Stuhmer, Thorsten
    Teufel, Eva
    Barrio-Garcia, Clara
    Chatterjee, Manik
    Schreder, Martin
    Das Gupta, Mithun
    Rosenwald, Andreas
    Tibes, Raoul
    Braggio, Esteban
    Stewart, A. Keith
    Bargou, Ralf C.
    Einsele, Hermann
    Kortum, K. Martin
    BLOOD, 2016, 128 (22)
  • [4] Molecular basis of bortezomib resistance:: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
    Oerlemans, Ruud
    Franke, Niels E.
    Assaraf, Yehuda G.
    Cloos, Jacqueline
    van Zantwijk, Ina
    Berkers, Celia R.
    Scheffer, George L.
    Debipersad, Kabir
    Vojtekova, Katharina
    Lemos, Clara
    van der Heijden, Joost W.
    Ylstra, Bauke
    Peters, Godefridus J.
    Kaspers, Gertjan L.
    Dijkmans, Ben A. C.
    Scheper, Rik J.
    Jansen, Gerrit
    BLOOD, 2008, 112 (06) : 2489 - 2499
  • [5] Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma
    Altavilla, G.
    Arrigo, C.
    Marabello, G.
    Galletti, G.
    Santarpia, M.
    Sauta, M.
    Pitini, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Spectrum and functional validation of PSMB5 mutations in multiple myeloma
    Barrio, Santiago
    Stuehmer, Thorsten
    Da-Via, Matteo
    Barrio-Garcia, Clara
    Lehners, Nicola
    Besse, Andrej
    Cuenca, Isabel
    Garitano-Trojaola, Andoni
    Fink, Severin
    Leich, Ellen
    Chatterjee, Manik
    Driessen, Christoph
    Martinez-Lopez, Joaquin
    Rosenwald, Andreas
    Beckmann, Roland
    Bargou, Ralf C.
    Braggio, Esteban
    Stewart, A. Keith
    Raab, Marc S.
    Einsele, Hermann
    Kortuem, K. Martin
    LEUKEMIA, 2019, 33 (02) : 447 - 456
  • [7] Spectrum and functional validation of PSMB5 mutations in multiple myeloma
    Santiago Barrio
    Thorsten Stühmer
    Matteo Da-Viá
    Clara Barrio-Garcia
    Nicola Lehners
    Andrej Besse
    Isabel Cuenca
    Andoni Garitano-Trojaola
    Severin Fink
    Ellen Leich
    Manik Chatterjee
    Christoph Driessen
    Joaquin Martinez-Lopez
    Andreas Rosenwald
    Roland Beckmann
    Ralf C. Bargou
    Esteban Braggio
    A. Keith Stewart
    Marc S. Raab
    Hermann Einsele
    K. Martin Kortüm
    Leukemia, 2019, 33 : 447 - 456
  • [8] AMPLIFICATION AND OVEREXPRESSION OF THE PSMB5 GENE CONTRIBUTE TO BORTEZOMIB RESISTANCE IN RE-TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
    Altavilla, Giuseppe
    Arrigo, Carmela
    Sauta, Maria Grazia
    Galletti, Giuseppe
    Gnani, Alessandro
    Pettineo, Giuseppe
    Buemi, Barbara
    Pitini, Vincenzo
    ANNALS OF ONCOLOGY, 2009, 20
  • [9] Proteasome Activity Not M-Protein Production Influences Multiple Myeloma (MM) Responsiveness to Bortezomib (BZB): The Key Role of PSMB5
    Zhou, Ping
    Ma, Xun
    Comenzo, Raymond L.
    BLOOD, 2011, 118 (21) : 1489 - 1490
  • [10] Second Generation Proteasome Inhibitors in Multiple Myeloma
    Gozzetti, Alessandro
    Papini, Giulia
    Candi, Veronica
    Brambilla, Corrado Zuanelli
    Sirianni, Santina
    Bocchia, Monica
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (07) : 920 - 926